BioNTech SE, a worldwide next-generation immunotherapy company, has entered a settlement with CureVac N.V. and GSK plc, and have obtained a non-exclusive license for mRNA-based Covid-19 and influenza products, and have dismissed all ongoing...
On Friday, Union Minister of State (IC) Science & Technology, Earth Sciences, MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr. Jitendra Singh inaugurated India’s first-of-its-kind state-of-the-art Animal Stem Cell Biobank
Entod Pharmaceuticals, a leader in ophthalmology, ENT, and dermatology medicines, has announced a number of innovative changes among its specialty divisions that will help to strengthen India’s position in global pharmaceutical R&D.
L V Prasad Eye Institute (LVPEI) is recognised as one of the forefront global centres for corneal neurotization surgery that has performed over 40 surgeries with surgical success rates similar to other established centres worldwide.
Meril, a global leader in advanced medical solutions, brought together some of India’s most distinguished oncology experts at OncoXchange, a high-impact panel discussion held at Meril Academy, Aloft Hotel, Aerocity, New Delhi.
.png "Lupin launched Glucagon for injection USP, 1 mg/Vial")
Lupin Limited, an Indian pharmaceutical company situated in Mumbai, has recently launched Glucagon for injection USP, 1 mg/Vial, in America. It is a generic version of Glucagon injection manufactured by Eli Lilly and is contained in an emergency...
Centrient Pharmaceuticals, a global leader in sustainable B2B manufacturing of antibiotics, statins, and antifungals, has officially joined the United Nations Global Compact (UNGC), the world’s largest corporate sustainability initiative...
The Kerala branch of the Indian Pharmaceutical Association (IPA) is launching a series of training programs over the next year to boost the skills of pharmacy students, working pharmacists, and other professionals in the field...
Cosmo Pharmaceuticals N.V., a global leader in AI-powered healthcare and specialty pharmaceuticals, has renewed its multi-year manufacturing and supply agreement with Takeda for Mesalazine
.jpeg "Biocon Bets Big on Insulin and GLP-1 Drugs to Expand Market Reach")
India’s biopharmaceutical sector is witnessing a significant shift as Biocon intensifies its dual focus on insulin and GLP-1 therapies, positioning itself strongly in two high-growth segments. With decades of expertise in biosimilar insulins, the Ben
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")